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ABSTRACT
Background Patients with cardiovascular disease (CVD) 
commonly experience depressive symptoms which 
is associated with adverse outcome and increased 
mortality. Examining the baseline characteristics of 
cardiac rehabilitation (CR) patients that determine 
Hospital Anxiety and Depression Scale (HADS) 
depression outcome may facilitate adjustments in CR 
programme delivery. This study aims to investigate 
whether comorbidities, demographic and clinical 
characteristics of patients, with new- onset post- cardiac 
event depressive symptoms, determine change in their 
depression following CR.
Methods Analysing the routine practice data of British 
Heart Foundation National Audit of Cardiac Rehabilitation 
between April 2012 and March 2018, an observational 
study was conducted. Patients with new- onset post- 
cardiac event depressive symptoms and no previous 
documented history of depression constituted the study 
population.
Results The analyses included 64 658 CR patients 
(66.24±10.69 years, 75% male) with new- onset HADS 
measures, excluding patients with a history of depression. 
The comorbidities determining reduced likelihood of 
improvement in depression outcomes after CR were 
angina, diabetes, stroke, emphysema and chronic back 
problems. In addition, higher total number of comorbidities, 
increased weight, a higher HADS anxiety score, smoking at 
baseline, physical inactivity, presence of heart failure and 
being single were other signiicant determinants. However, 
receiving coronary artery bypass graft treatment was 
associated with better improvement.
Conclusion The study identiied speciic baseline 
comorbid conditions of patients with new- onset depressive 
symptoms including angina, diabetes, stroke, emphysema 
and chronic back problems that were determinants of 
poorer mental health outcomes (HADS) following CR. 
Higher total number of comorbidities, increased weight, 
physical inactivity, smoking, presence of heart failure and 
being single were other determinants of a negative change 
in depression. These indings could help CR programmes 
focus on tailoring the CR intervention around comorbidity, 
physical activity status, weight management and 
smoking cessation in patients with new- onset depressive 
symptoms.
INTRODUCTION
The association of depression with increased 
mortality is widely demonstrated in patients 
with cardiovascular disease (CVD) in a 
previous meta- analysis1 2 as well as its associa-
tion with poor cardiac prognosis. The Amer-
ican Heart Association recently published 
a scientific statement which recommends 
elevating depression to the status of a risk 
factor for mortality and cardiac morbidity in 
patients with CVD.3 Depression is a common 
condition, one in five of patients with CVD 
experience depression4 and it is one of the 
Key questions
What is already known about this subject?
 Ź Patients with cardiovascular disease often expe-
rience depressive symptoms that is associated 
with increased mortality and adverse outcomes. 
However, there is a lack of studies which investigate 
baseline characteristics of cardiac rehabilitation 
(CR) patients that determine depression outcome in 
patients with new- onset depressive symptoms.
What does this study add?
 Ź The current study is the irst to examine the pa-
tient characteristics that determine the change in 
depressive symptoms following CR, speciically in 
patients with new- onset post- cardiac event depres-
sive symptoms.
How might this impact on clinical practice?
 Ź This paper shows that patients with new- onset de-
pressive symptoms are less likely to improve their 
depression levels following CR when they have such 
comorbidities and patient characteristics at base-
line: comorbidities of angina, diabetes, stroke, em-
physema, chronic back problems, and higher total 
number of comorbidities, increased weight, physical 
inactivity, smoking, presence of heart failure and be-
ing single according to multivariate analysis results. 
These indings could enable CR programmes to tai-
lor the CR intervention around comorbidities, physi-
cal activity status, weight management and smoking 
cessation in this speciic patient population.
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leading causes of years lived with disability globally.5 
Depression is associated with loss of productivity and 
treatment non- compliance in patients with CVD,6 along 
with increased inpatient and outpatient healthcare utili-
sation costs.7
Cardiac rehabilitation (CR) is essential for the compre-
hensive management of patients with CVD, and is a 
multicomponent programme that targets secondary 
prevention and also improvement of patient’s psychoso-
cial health.8 A recent Cochrane review has demonstrated 
that CR is effective9 and it reduces depressive symptoms.10 
The assessment of depression is widely recommended by 
the recent clinical guidelines as it is a well- established risk 
factor for worse cardiac prognosis and outcomes.3 8 11 12
The time onset of depressive symptoms has been the 
focus point in the recent studies with regard to cardiac 
morbidity and mortality.13–16 Although some studies 
revealed that patients with history of depression prior to 
cardiac event experienced increased cardiac morbidity 
and mortality,13 14 other studies have found that patients 
with new- onset depressive symptoms after cardiac event 
were more likely to experience adverse cardiac events 
and mortality.15 16 A recent National Audit of Cardiac 
Rehabilitation (NACR)–based study has contributed to 
this literature and found that baseline characteristics of 
patients with history of depression such as higher anxiety, 
higher total number of comorbidities, smoking, physical 
inactivity and male gender were determinants of their 
depression levels following CR.17 Moreover, previous 
studies were unable to be inclusive of different types 
of comorbidities and their association with depression 
outcome in CR setting, and were also unable to adjust for 
heart failure (HF) and cardiac treatments. Therefore, the 
current study is the first to examine the impact of comor-
bidities and other patient characteristics on the depres-
sion outcome in the context of UK CR programmes.
METHODS
The strengthening the reporting of observational studies 
in epidemiology (STROBE) checklist was employed to 
report this study.18
Data collection
Patient data based within NACR database were extracted 
and analysed. The primary aim of the NACR is to monitor 
CR programmes and improve the quality of delivery in 
UK CR centres and outcomes. To be able to achieve 
this, CR programmes collect individual patient data 
under section 251 approval of the NHS Act 2006 which 
is entered and secured in an online system held by NHS 
Digital. The identifiable patient data can be collected by 
the approval that NHS Digital has and these data are then 
anonymised before being made available for the NACR. 
Thus, due to this data governance process, there was no 
need to gain patient consent from each individual. NHS 
Digital reviews the data governance agreement between 
NACR and NHS Digital annually. In the present study, 
no additional NHS ethical approval was required because 
the data are used in line with NACR purposes and 
complies with data protection regulations. Currently, the 
number of CR services entering the data electronically is 
229 which is 80% of all programmes.19 The data include 
patients’ initiating event, demographics, risk factors, 
treatment, medication and outcomes who undergo CR 
in the UK.
Participants
The analysis was based and data extracted from the 
NACR between 1 April 2012 and 31 March 2018. The 
study population included patients with myocardial 
infarction (MI) and HF and those who receive treatment 
of percutaneous coronary intervention (PCI) and coro-
nary artery bypass graft (CABG) as recommended in the 
clinical guidelines.20 21 All the eligible patients who did 
not present with prior history of depression and who had 
pre- HADS and post- HADS assessments recorded in CR 
(n=64 658) were selected as participants during the study 
period.
Measures
Patients who had no reported prior history of depression 
and had valid pre- CR and post- CR HADS measurements 
were selected using the NACR data set, and with this 
approach, eligible patient population was defined for the 
study sample. History of depression in the NACR data is 
confirmed by CR practitioners with case note review and 
by patients if they have ever been diagnosed or treated by 
a doctor for depression.
Hospital Anxiety and Depression Scale (HADS)
The HADS is an assessment tool in the form of a self- 
answered questionnaire which is employed for screening 
depressive symptoms in clinical practice. The HADS is one 
of the psychosocial health measurements that is recom-
mended for assessment before and after CR to provide 
patients with tailored CR according to their needs.8 There 
are 14 items in HADS, 7 of which cover anxiety symptoms 
and 7 depressive symptoms. The score of 0 to 3 can be 
assigned to each item, accordingly a minimum of 0 and 
maximum of 21 can be received for the separate anxiety 
and depression scores, and the higher the scores the 
worse the symptom is. The HADS has been demonstrated 
to be a reliable and valid measure for assessing anxiety 
and depression measurements, and is therefore recom-
mended to use with patients with CVD.22–24 In the current 
study, the analysis and the clinical cut- off point of 8 was 
used to categorise patients into patients with absence of 
new- onset depressive symptoms (<8) and presence of new- 
onset depressive symptoms (≥8) groups.24 The reason for 
this is that a systematic review has demonstrated that an 
optimal balance between sensitivity and specificity for 
HADS as a screening tool was often achieved at a cut- off 
score of 8 for both HADS anxiety and HADS depression, 
considering the specificity and sensitivity for both scales 
at roughly 0.80.23 The analysis used in the present study 
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then compared the patients with HADS <8 and HADS ≥8 
in a subgroup of patients without history of depression. In 
addition, baseline HADS anxiety scores that are routinely 
reported as part of HADS were employed to see whether 
it determines depression outcomes after CR.
Total number of comorbidities and comorbidity types
Total number of comorbidities is defined as the sum 
of the number of comorbidities that the patients had 
including angina, diabetes, stroke, emphysema, chronic 
back problems and others. Comorbidities are defined as 
the medical history of conditions in the NACR data which 
is confirmed by CR providers with case note review and 
by patients answering the question of whether they have 
been diagnosed or been treated for the condition.
Other variables
The patient demographics used in the analysis were 
age, gender and marital status (single/partnered). The 
English Index of Multiple Deprivation (IMD), a measure 
of deprivation used in England, was another patient 
demographic. Seven domains are applied to construct 
the IMD measure: employment, health deprivation and 
disability, income, crime, barriers to housing and services, 
living environment, education skills and training.25 In 
total, there are 32 844 sub- areas ranked from the most to 
least deprived areas. IMD was used to categorise patients 
into two quintiles where the first quintile, reported as 
‘lowest quintile’, means the most deprived areas and 
other quintiles categorised as the less deprived. Pre- 
CR, baseline smoking measurements are categorised 
according to whether the patient was a current smoker or 
non- smoker. Other included variables were weight (kg), 
moderate physical activity (150 min a week), presence 
of heart failure (yes/no) and cardiac treatment (PCI/
CABG/other/none). All the variables included in this 
paper have been chosen in line with the literature and 
baseline clinical assessment variables carried out by CR 
practitioners. These variables were explained in detail in 
previous publications.17 26 27
Statistical analysis
The data analyses were performed using the IBM SPSS 
software statistics V.25. Patients without prior history of 
depression who have pre- HADS and post- HADS assess-
ments recorded constituted the study population. A p 
value of <0.05 was considered to be statistically signifi-
cant. Summary statistics were presented as means, SD 
and percentages. The descriptive statistics were calcu-
lated, and the baseline characteristics compared between 
patients with absence of new- onset depressive symptoms 
and presence of new- onset depressive symptoms, using 
t- tests for continuous variables and χ2 tests for categor-
ical variables. Cohen’s d effect size was calculated for 
continuous variables and phi or Cramer’s V effect size 
was reported for categorical variables. A binary logistic 
regression model was conducted in order to investigate 
which variables determined improvement in the HADS 
depressive symptoms following CR.
RESULTS
A total of 64 658 patients without prior history of depres-
sion who had completed CR with valid pre- HADS and post- 
HADS assessments constituted the study population. From 
this population of 64 658 participants, 17.4% presented 
with new- onset depressive symptoms (HADS ≥8) and 82.6% 
were, for this study, defined as having an absence of new- 
onset depressive symptoms (HADS <8). The total popu-
lation during the study time period and the study sample 
size are shown in the flow diagram in figure 1. At CR base-
line assessment, patients with new- onset depressive symp-
toms (HADS ≥8 group) differed from the HADS <8 group 
in terms of 11 characteristics in that they were younger, 
female, single, from areas of higher deprivation, had a 
higher total number of comorbidities, more weight, higher 
anxiety scores, physically inactive, more likely to smoke, 
presence of heart failure and less likely to receive cardiac 
treatments. The HADS ≥8 group presented with a higher 
Figure 1 Study low diagram. CR, cardiac rehabilitation; 
HADS, Hospital Anxiety and Depression Scale; NACR, 
National Audit of Cardiac Rehabilitation.
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proportion of comorbidities including angina, diabetes, 
stroke, emphysema, and chronic back problems compared 
with those with an HADS <8 group. Baseline characteristics 
of patients according to high and low HADS scores (HADS 
<8, absence of new- onset depressive symptoms; HADS ≥8, 
presence of new- onset depressive symptoms) are presented 
in table 1.
A binominal logistic regression was performed to ascer-
tain the impact of the 11 patient characteristics and 5 iden-
tified comorbidities on the likelihood that participants’ 
depression symptoms improved between HADS depres-
sion symptom group following CR. The logistic regression 
model was statistically significant, χ2(18)=359.814, p<0.001. 
The model correctly classified 63.3% of the cases. Hosmer 
and Lemeshow test shows that the model was a good fit 
(p=0.208). Of the 16 predictor variables, 13 were statisti-
cally significant: weight, HADS anxiety score measurement, 
physical inactivity, smoking, marital status, total number of 
comorbidities, presence of heart failure, CABG or other 
treatments, comorbidities of angina, diabetes, stroke, 
emphysema and chronic back problems (as shown in 
table 2).
Patients with higher number of comorbidities had 0.932 
times lower odds of residing in low HADS levels after CR. 
Increased HADS anxiety score was associated with a 10% 
decreased likelihood of improved depressive symptoms 
after CR. Physical inactivity was also associated with 18% 
reduced odds of moving to absence of HADS depressive 
symptoms category. Smoking was associated with 25% 
decreased likelihood of improvement in HADS range after 
CR. Increased weight and being single were also negative 
determinants of change in depression. Patients who have 
the comorbidity of emphysema had 0.665 times lower odds 
of having improved depressive symptoms which is followed 
by having the following conditions: comorbidity stroke, 
comorbidity angina, comorbidity chronic back problems 
and comorbidity diabetes (0.718, 0.778, 0.812 and 0.830 
times, respectively). Patients who had heart failure were 
25% less likely to improve their depressive symptoms 
following CR. In addition, patients who receive CABG and 
other treatments were 43% and 36% increased odds of 
having improved depressive symptoms.
DISCUSSION
Previously, the association of depressive symptoms with 
poor cardiac prognosis, cardiac mortality and overall 
mortality is well established in the literature. Yet, there 
Table 1 Baseline characteristics for presence and absence of new onset HADS depressive symptoms groups
Variables
HADS <8 group 
(n=53 427) HADS ≥8 group (n=11 231)
P value Effect sizeMean±SD Mean±SD
Age 66.56±10.54 64.73±11.29 <0.001 0.17
Total comorbidities 2.34±1.44 2.58±1.56 <0.001 0.16
Weight 82.35±16.46 83.11±18.40 <0.001 0.05
HADS anxiety score 4.38±3.31 9.56±4.03 <0.001 1.50
Gender female % 24.1 29.3 <0.001 0.05
150 min physical activity a week (yes) % 46.2 28.5 <0.001 0.14
Smoking (yes) % 4.7 8.3 <0.001 0.06
Single % 20.1 24.8 <0.001 0.04
IMD (most deprived) % 9.6 15.0 <0.001 0.07
Heart failure (yes) % 6.4 10.1 <0.001 0.06
Comorbidity     
  Angina % 18.4 19.5 0.008 0.01
  Diabetes % 19.1 24.6 <0.001 0.05
  Stroke % 4.2 5.9 <0.001 0.03
  Emphysema % 1.7 2.6 <0.001 0.03
  Chronic back problems % 11.5 14.3 <0.001 0.03
Cardiac treatment
  No treatment % 8.5 11 <0.001 0.05
  PCI % 50.3 44.5
  CABG % 16.6 16.2
  Other treatment % 24.6 28.3
CABG, coronary artery bypass graft; HADS, Hospital Anxiety and Depression Scale; IMD, Index of Multiple Deprivation; PCI, percutaneous 
coronary intervention.
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remained a need for thorough investigation of the patient 
characteristics including demographics, comorbidities 
and clinical characteristics associated with new- onset 
depressive symptoms. Thus, the current study examined 
the characteristics of patients with new- onset depressive 
symptoms in CR patients to a greater extent. The findings 
of our study demonstrated that baseline characteristics 
of patients with new- onset depressive symptoms deter-
mine the change in the depression outcome after CR. 
More specifically, patient characteristics such as having 
a higher number of comorbidities and the comorbidities 
of angina, diabetes, stroke, emphysema, chronic back 
problems, increased weight, higher anxiety scores, phys-
ical inactivity, smoking, presence of heart failure, CABG 
treatment and being single were significant predictors of 
depression outcomes following CR. However, age, gender 
and IMD were not able to determine depressive symptoms 
after CR in patients with new- onset depressive symptoms.
A finding of note was that having a higher total 
number of comorbidities was a significant determinant 
of depressive symptoms. A prior study employing RCT 
data in their analysis was unable to find an association 
between comorbidities and depressive symptoms,28 which 
perhaps could be explained by the younger population 
(mean age 59.1±19.8) compared with the current study 
(66.24±10.69). Indeed, a recent meta- analysis of CR 
trials recommends future trials involve patients who are 
more representative of the broader patients with CVD, 
including patients with comorbidities.9 In addition, 
patients who present with multiple comorbidities are 
found to be less likely to be referred to or uptake CR 
which is a primary challenge for healthcare providers 
and CR programmes.29 30 Yet, attending CR enables 
patients with multiple comorbidities to benefit in terms 
of improving their functional capacity and psychosocial 
conditions.30 31
Another finding was that the comorbidity of diabetes 
was associated with 17% reduced likelihood of improve-
ment in depressive symptoms following CR (OR 0.830 
95% CI 0.714 to 0.965). Patients with diabetes attending 
CR had reduced physical fitness and increased cardiac 
risk factors compared with non- diabetic patients.32 Indi-
viduals with diabetes who participate or complete CR 
were also significantly less likely than non- participants 
or no- completers to experience mortality.33 34 When the 
condition of patients with diabetes was taken into account 
in terms of having a greater cardiac risk profile and 
lower programme participation rate, recommendations 
have been made to CR programmes to target patients 
with diabetes and involve them in CR.35–37 In addition, 
considering the prevalence of diabetes has been steadily 
increasing over time,38 the medical management of 
diabetes may relatively be necessary and perhaps can 
reduce depressive symptoms.
Table 2 Coeficients of the model determining change in depression whether a patient has improved depressive symptoms 
after CR
Variable B SE P value OR Lower 95% CI Upper 95% CI
Age −0.005 0.003 0.138 0.995 0.990 1.001
Total no of comorbidities −0.071 0.024 0.004 0.932 0.888 0.977
Weight −0.008 0.002 <0.001 0.992 0.989 0.996
HADS anxiety score −0.105 0.008 <0.001 0.900 0.885 0.915
150 min a week physical activity (no) −0.196 0.067 0.003 0.822 0.721 0.937
Smoking (yes) −0.281 0.118 0.018 0.755 0.599 0.952
Gender (male) −0.119 0.075 0.112 0.888 0.767 1.028
Marital status (single) −0.273 0.073 <0.001 0.761 0.660 0.877
IMD (most deprived) −0.015 0.088 0.864 0.985 0.829 1.171
Angina (yes) −0.251 0.083 0.003 0.778 0.661 0.916
Diabetes (yes) −0.186 0.077 0.016 0.830 0.714 0.965
Stroke (yes) −0.332 0.136 0.015 0.718 0.550 0.937
Emphysema (yes) −0.407 0.207 0.049 0.665 0.443 0.999
Chronic back problems (yes) −0.208 0.095 0.028 0.812 0.674 0.977
Heart failure (yes) −0.289 0.105 0.006 0.749 0.610 0.919
Cardiac treatment (reference: no treatment)
  PCI 0.078 0.116 0.499 1.082 0.862 1.357
  CABG 0.362 0.132 0.006 1.436 1.108 1.861
  Other treatment 0.313 0.119 0.008 1.367 1.084 1.725
  Constant 2.720 0.320 <0.001 – – –
B, regression coeficient; CABG, coronary artery bypass graft; CR, cardiac rehabilitation; HADS, Hospital Anxiety and Depression Scale; IMD, 
Index of Multiple Deprivation.
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The stroke comorbidity was influential on the depres-
sion outcome in patients with new- onset depressive 
symptoms after CR. It was associated with reduced odds 
of improvement in depressive symptoms following CR 
(OR 0.718, 95% CI 0.550 to 0.937). Previous studies have 
shown that patients with stroke comorbidity were less 
likely to be referred to29 and uptake CR.30 However, the 
study of Marzolini et al39 found that patients who had a 
stroke who undergo CR improve their functional capacity 
and cardiovascular fitness; for that reason, including 
patients who had a stroke in CR can be beneficial.
Emphysema is the comorbidity which had the highest 
impact, among the comorbidities, on the change in 
depressive symptoms following CR. Having emphy-
sema at baseline was associated with 34% reduced odds 
of improvement in the depressive symptoms after CR. 
Patients with chronic obstructive pulmonary disease 
(COPD) and CVD experience problems of breathless-
ness and disability in the context of multi- morbidity, thus, 
cardiac rehabilitation services are recommended to take 
positive action by providing tailored intervention options 
for patients with COPD.40 In addition, angina and chronic 
back problems were other comorbidities that were nega-
tive determinants of depression outcomes following CR 
with OR 0.778, 95% CI 0.661 to 0.916 and OR 0.812, 
95% CI 0.674 to 0.977, respectively. Overall, all of the 
comorbidities that were mentioned were negative deter-
minants of improvement in CR patient’s depressive symp-
toms following CR in patients who present with new- onset 
depressive symptoms. This is the first study showing the 
influence of the variety of comorbidities on CR outcomes 
in patients with new- onset depressive symptoms.
Our finding of clinical relevance was that smoking, phys-
ical inactivity and weight were modifiable CVD risk factors 
having an unfavourable impact on depression outcomes 
after CR. These factors were negative determinants of 
improvement in depression in patients with new- onset 
depressive symptoms following CR (OR 0.755, 95% CI 
0.599 to 0.952; OR 0.822, 95% CI 0.721 to 0.937; OR 
0.992, 95% CI 0.989 to 0.996, respectively). These results 
were in line with previous systematic reviews conducted 
in the general population,41–43 and other cohort studies 
that involved patients with CVD.44 45 However, these 
studies were unable to include CR patients and specifi-
cally patients with new- onset depressive symptoms. The 
current study, on the other hand, included patients who 
undergo CR and assessed outcome of change in depres-
sive symptoms following CR. Prior studies have tended to 
focus on CR utilisation and depression with little in the 
way of evidence regarding factors determining outcome 
for patients with new- onset depression.
Another finding of the current study is patients with 
new- onset depressive symptoms and who have higher 
anxiety score at baseline were less likely to improve their 
depression symptoms (OR 0.900, 95% CI 0.885 to 0.915). 
This finding demonstrates that anxiety and depression 
are interrelated and associated with poor outcomes 
which was in accordance with a previous study.46 In the 
USA- based study, 622 patients with HF were included and 
it was revealed that anxiety, measured by Brief Symptoms 
Inventory, was associated with depressive symptoms in 
both men and women. In our study, HADS anxiety score 
measurement was employed for the assessment instead 
and still confirmed this association. In addition, the 
current study is first to show that patients with HF were 
25% less likely to improve their depressive symptoms 
following CR. This result, perhaps, may explain why a 
recent CR trial was unable to demonstrate improvement 
in depressive symptoms in HF population.47 Thus, patients 
with HF may need additional psychosocial support from 
CR teams which may require further investigation in 
future studies. Moreover, the cardiac treatment was also 
adjusted in the multivariate analysis in the current study 
and it has been found that patients who receive the treat-
ment of CABG were 43% more likely to have improved 
depressive symptoms.
In the current study, considering patient demographics, 
being single was associated with 24% reduced likelihood 
of improved depressive symptoms after CR (OR 0.761, 
95% CI 0.660 to 0.877). Having partner support may 
improve patients’ coping with their illness and thereby 
improve their depression symptoms. The association of 
being single with increased depressive symptoms has also 
been found in meta- analysis of 24 cross- sectional and 8 
longitudinal studies conducted by Yan et al.48 This study 
included 52 803 individuals from the general population 
of people aged ≥55 years. In our study, other patient 
demographics of age, gender and IMD were unable to 
significantly predict the depression outcome. In the 
multivariate analysis, the adjustments were made for other 
cardiac risk factors and comorbidities which may have an 
impact on this result. Bachmann et al49 recently found 
an association between lower neighbourhood socioeco-
nomic context and reduced likelihood of participation 
in CR. In addition, patients who live in socially deprived 
areas were more disadvantaged than ones who live in less 
deprived neighbourhoods in terms of inhabiting poor 
health behaviours such as smoking and being physically 
inactive.50 In the current study, although the IMD was 
found to be associated with depressive symptoms at base-
line assessment, after adjusting for other covariates it has 
no longer reached statistical significance.
Finally, the model of logistic regression was chosen to 
match with other literature in this field; for comparisons 
to be made, future work may look to invoke a propensity- 
based linear model of change accounting for included 
and non- included variables.
Limitations
In order to examine the determinants of outcome, 
specifically in patients with new- onset depressive symp-
toms, patients with prior history of depression have 
been excluded from our population. However, looking 
at the characteristics of our sample, it was representa-
tive of all available patients during the study time scale 
(n=277 521), mean age was 66.24 compared with 65.06, 
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25% female compared with 27%, and other variables 
did not differ by more than 4%. The sample was nation-
ally representative of patients with new- onset depressive 
symptoms in the UK, yet, it is important to state that not 
all CR programmes provide a full record of patients who 
complete CR and in fact, in NACR data, 36.6% did not 
have follow- up assessment which may have an influence 
on the representativeness of the sample.19 A strength of 
this study was the use of an observational approach by 
employing analysis of routinely collected clinical data 
which enabled us to generate real- world understanding. 
In addition, the data involved more patients with multi- 
comorbidities and higher female percentage than prior 
RCTs.9 However, as this is a registry- based study, it should 
be noted that observational studies do not allow to draw 
causal conclusions, only association. The analysis was not 
able to take account of the treatment with antidepressant 
medication or diagnosis of depression in the CR period, 
as this was not recorded in the NACR data set.
CONCLUSION
The primary objective of this study was to ascertain 
whether comorbidities, demographic and clinical char-
acteristics of patients with new- onset post- cardiac event 
depressive symptoms determine improvement in their 
depression following CR. Baseline characteristics of 
patients with new- onset depressive symptoms such as 
comorbid conditions of angina, diabetes, stroke, emphy-
sema and chronic back problems, as well as higher total 
number of comorbidities, increased weight, physical inac-
tivity, smoking, presence of heart failure and being single 
were negative determinants of improvement in depres-
sion following CR. However, receiving CABG or other 
treatments were positive determinants of improvement. 
Our findings could promote CR programmes that focus 
on tailoring the CR intervention around comorbidity, 
physical activity status, weight management and smoking 
cessation in patients with new- onset depressive symptoms.
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